The preclinical discovery and development of ezogabine for the treatment of epilepsy

Author： Jankovic Slobodan Ilickovic Ivana

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.11, 2013-11, pp. : 1429-1437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The discovery and development of perampanel for the treatment of epilepsy

By Hanada Takahisa

Expert Opinion on Drug Discovery, Vol. 9, Iss. 4, 2014-04 ,pp. : 449-458

Informa Healthcare

Access to resources Recommend Favorite

Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with Epilepsy

By Deeks Emma D.

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 887-900

Adis International

Access to resources Recommend Favorite

Preclinical discovery of duloxetine for the treatment of depression

By Torres-Sanchez Sonia Perez-Caballero Laura Mico Juan Antonio Elorza Julian Berrocoso Esther

Expert Opinion on Drug Discovery, Vol. 7, Iss. 8, 2012-08 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite

Fluoxetine: a case history of its discovery and preclinical development

By Perez-Caballero Laura Torres-Sanchez Sonia Bravo Lidia Mico Juan Antonio Berrocoso Esther

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 567-578

Informa Healthcare

Access to resources Recommend Favorite

Ezogabine: Development and Role in the Management of Epileptic Seizures

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 5, 2013-04 ,pp. : 697-705

Bentham Science Publishers

Access to resources Recommend Favorite